Director at Apollomics (APLM) gains 500 shares from vested RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Apollomics Inc. director Jan Chen-Huan reported a routine equity compensation event, with 500 Restricted Stock Units vesting into 500 Class A Ordinary Shares on June 15, 2026. Each RSU represents a right to receive one Class A share. Following this vesting and related derivative exercise, Chen-Huan directly holds 1,500 Class A Ordinary Shares and 500 RSUs, with no open-market purchases or sales disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
500 shares exercised/converted
Mixed
2 txns
Insider
Jan Chen-Huan
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 500 | $0.00 | -- |
| Exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 500 shares (Direct, null);
CLASS A ORDINARY SHARES — 1,500 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 500 shares vested on each of February 9, 2026, March 15, 2026 and June 15, 2026 and an additional 500 shares will vest on September 15, 2026. This transaction represents the vesting of 500 RSUs on June 15, 2026.
Key Figures
RSUs vested: 500 units
Shares received from vesting: 500 shares
Shares held after transaction: 1,500 shares
+2 more
5 metrics
RSUs vested
500 units
Vested into Class A Ordinary Shares on June 15, 2026
Shares received from vesting
500 shares
Class A Ordinary Shares from RSU conversion at $0.0000
Shares held after transaction
1,500 shares
Total direct Class A Ordinary Shares following June 15, 2026
Remaining RSUs
500 units
Restricted Stock Units outstanding after June 15, 2026 vesting
Exercise price
$0.0000 per share
Conversion of RSUs into Class A Ordinary Shares
Key Terms
Restricted Stock Units, Class A Ordinary Shares, derivative exercise/conversion, Form 3/A
4 terms
Restricted Stock Units financial
"This transaction represents the vesting of 500 RSUs on June 15, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
Form 3/A regulatory
"previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026."
An amended Form 3 (Form 3/A) is a corrected or updated disclosure filed with regulators that revises an insider’s initial report of their ownership in a public company — typically for officers, directors or large shareholders. Investors use it like a corrected inventory list: it clarifies who owns how many shares and whether earlier reports had errors, helping assess insider confidence, possible conflicts and the accuracy of ownership records that can affect stock valuation and trust.
FAQ
What insider transaction did Apollomics (APLM) disclose for Jan Chen-Huan?
Apollomics director Jan Chen-Huan reported 500 Restricted Stock Units vesting into 500 Class A Ordinary Shares on June 15, 2026. This is a routine equity compensation event, not an open-market share purchase or sale.
What do the Apollomics (APLM) RSU footnotes say about this vesting?
The footnotes explain that each RSU equals one Class A share and that 500 RSUs vested on February 9, March 15, and June 15, 2026. Another 500 RSUs are scheduled to vest on September 15, 2026 under the same grant.
How many Restricted Stock Units remain for Apollomics (APLM) director Jan Chen-Huan?
Following the June 15, 2026 vesting of 500 RSUs, 500 Restricted Stock Units remain outstanding. These RSUs represent contingent rights to receive additional Apollomics Class A Ordinary Shares as future vesting dates are met.